LC
CMPS

Lindbrook Capital’s Compass Pathways CMPS Stock Holding History

Lindbrook Capital’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-144
Closed -$2K – 2656
2022
Q2 		$2K Buy
+144
New +$1.45K ﹤0.01% 1926

Other funds holding CMPS

AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Lindbrook Capital's CMPS Position: Q3 2022 in Review

Lindbrook Capital sold out of Compass Pathways (CMPS) in Q3 2022, closing a stake of 144 shares — an estimated $2K sold.

Lindbrook Capital first reported a position in CMPS in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 115 funds tracked by Wall St. Rank hold CMPS as of Q3 2022.

  • Lindbrook Capital reported no remaining Compass Pathways position as of Q3 2022 after selling out during the quarter.
  • Lindbrook Capital sold 144 Compass Pathways shares in Q3 2022, an estimated $2K.
  • Lindbrook Capital first reported a position in Compass Pathways in Q2 2022 and held it in 1 quarter.
  • Lindbrook Capital's Compass Pathways position peaked at $2K in Q2 2022.
  • 115 funds tracked by Wall St. Rank held Compass Pathways as of Q3 2022.

Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.